Starting with the world’s best science,
we build world-changing businesses.

Since 2015, we have worked with over 200 of Oxford’s leading academics to build a portfolio of more than 100 companies, worth over $2 billion, all based on Oxford science.

From the Oxford-vaccine to breakthroughs in quantum computing, nuclear fusion and advanced medical diagnostics, our companies all have the potential to positively impact lives on a global scale.

Scientific breakthroughs can solve the world’s toughest problems, from infectious diseases to natural resource shortages and rapid climate change, but only when they make it out of the lab.

We build world-changing businesses, bringing Oxford science to the world faster.



We're excited to share the news that @YASAMotors has been acquired by @MercedesBenzUK.

This acquisition will further accelerate the positive impact of YASA's world-leading technology - supporting the adoption of electric vehicles globally.

#electricvehicles #oxford #automotive

Financial Times@FT

Mercedes buys UK start-up Yasa as it steps up electric transition

Exciting news from Circadian Therapeutics!
Circadian Therapeutics and ARQUIMEA have signed an agreement for the co-development of molecules as an innovative treatment for nervous system diseases such as ALS, Parkinson’s, and Alzheimer’s disease.
@sleepscientist1 #healthcare

Fantastic to see @UniofOxford ranked as the top UK university for life sciences spinouts, with a special mention of OSI portfolio company @EvOx_Ltd!

#lifesciences #innovation #science @OxUInnovation

Stay up to date

Get the latest on cutting-edge developments in our portfolio, straight to your inbox.